Finally, Jung et al. [93] also reported an alternation of DNA copy number amplifications and mRNA upregulation of NGF that was correlated with a worse survival in the same cohort of patients manly affected by invasive ductal carcinoma and who underwent neoadjuvant chemotherapy. The gene discussed is NGF; the disease is invasive ductal breast carcinoma.